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Edited by Vladimir SkulachevAbstract Bax-induced lethality in yeast is accompanied by
morphological changes in mitochondria, giving rise to a reduced
number of swollen tubules. Although these changes are com-
pletely abolished upon coexpression of the Bax inhibitor, Bcl-2,
coexpression of Bax with Bax inhibiting-glutathione S-transfer-
ase (BI-GST) leads to aggregation, but not fusion of the
mitochondria. In addition, Bax aﬀects the integrity of yeast
vacuoles, resulting in the disintegration and eventual loss of the
organelles, and the disruption of intracellular protein traﬃc.
While Bcl-2 coexpression only partially corrects this phenotype,
coexpression of BI-GST fully restores the organelles, indicating
a diﬀerent mode of protection exerted by Bcl-2 and BI-GST.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The Bcl-2 family of proteins is at the core of the metazoan
cell death machinery. It includes pro-survival and pro-apop-
totic members, several of which appear to have an impact on
survival pathways in heterologous systems that do not contain
endogenous Bcl-2 proteins. Plants expressing Bcl-2 and Bcl-
XL, or CED-9 display resistance to several necrotrophic fungal
pathogens and to a necrogenic virus [1–3]. In yeast, Bcl-2 and
CED-9 inhibit oxidative stress-induced programmed cell death
(PCD) [4]. Conversely, Bax-expression in plants causes local-
ized tissue collapse in a manner resembling the hypersensitive
response, a PCD response of plants in defense against patho-
gens [5]. Moreover, human or plant genes isolated from yeast
genetic screens for Bax or Bak suppression have been associ-
ated with pro-survival eﬀects when expressed in their native or
a heterologous context [6–9].* Corresponding author. Fax: +30-28210-35001.
E-mail address: antonios@maich.gr (A.M. Makris).
Abbreviations: PCD, programmed cell death; ROS, reactive oxygen
species; GST, glutathione S-transferase; BI-GST, Bax inhibiting-GST;
HE, dihydroethidium; ALP, alkaline phosphatase; EA, ethacrynic
acid; BSO, buthionine sulfoximine; DWm, mitochondrial membrane
potential
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doi:10.1016/j.febslet.2004.04.012Bax, a mammalian proapoptotic member of this family, is
thought to alter organelle function by localizing to the outer
mitochondrial membrane and forming an ion channel [10].
Yeast cell death caused by Bax, and its close relative Bak,
appears relevant to its function in a physiological setting [11].
In a screen to identify plant inhibitors of Bax lethality in yeast,
we identiﬁed a glutathione S-transferase (GST), named Bax
Inhibiting-GST (BI-GST). In yeast, coexpression of BI-GST
with Bax restored glutathione to wild-type levels and preserved
mitochondrial function, while BI-GST expression protected
cells from prooxidant insults [12,13]. This study investigates
the eﬀects of Bax expression on yeast organelles. Changes in
mitochondrial morphology and function, together with dis-
ruptive eﬀects on the vacuole and on protein traﬃcking, are
reported. The suppression of Bax lethality by Bcl-2 and BI-
GST appears to be achieved in a diﬀerent mode in each case.
Bcl-2 mainly protects the mitochondria, whereas BI-GST
maintains the integrity of the vacuoles.2. Materials and methods
2.1. Flow-cytometric studies
EGY48 cells harboring the LexA-Bax construct (pGILDA/Bax) in
conjunction with pJG4-6/BI-GST and cells harboring only the BI-GST
construct were grown, stained, and processed as previously described
[12]. Dihydroethidium (HE; D-1168, Molecular Probes) at 4 lM was
used as an indicator of endogenous reactive oxygen species (ROS).
2.2. Fluorescent microscopy of yeast organelles
Mitotracker Red CMxROS (M-7512, Molecular Probes) was used to
stain mitochondria at a ﬁnal concentration of 2 lM for 20 min. Vac-
uolar membranes were stained with 4 lM MDY-64 (Y-7536, Molec-
ular Probes) for 5 min. The vacuolar lumen was stained with 50 lM
CMAC (Y-7531, Molecular Probes) for 20 min. Cells were washed
twice, resuspended in prewarmed PBS, applied on microscope slides,
and observed at 1000 magniﬁcation. To visualize the mitochondrial
matrix, plasmid pVT100U-mitGFP (which expresses GFP fused to a
mitochondrial matrix targeting sequence [14]) was introduced to yeast
cells. To monitor aspects of the vacuolar transport pathway, plasmid
GFP-alkaline phosphatase (ALP) (expressing a GFP fusion of the
vacuolar membrane protein ALP) was used [15].
2.3. Expression of BI-GST and Bax as GFP fusions in yeast
The ORF of GFP was PCR-ampliﬁed using primers that introduce
restriction sites for EcoRI and SalI at the 50 of the cDNA. The PCR
product was cloned into the pCRT7/CT TOPO vector (Invitrogen).
The ORF of BI-GST from the pBad/BI-GST vector [12] was insertedblished by Elsevier B.V. All rights reserved.
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sites, fusing it in frame to the N-terminus of GFP. The BI-GST/GFP
insert was subcloned into the EcoRI/XhoI sites of the yeast expression
plasmid pJG4-6. The ORF of Bax from the pGILDA/Bax vector was
subcloned in frame to the 30 of the EYFP cDNA, which was previously
inserted in the pJG4-6 yeast vector. Induction of EYFP-Bax caused
yeast lethality, conﬁrming functionality of the Bax fusion.Fig. 1. Changes in viability and intracellular ROS. (A) EGY48 cells
expressing LexA-Bax in the presence and absence of BI-GST were
grown in liquid gal-raﬀ/CM medium. Cells carrying empty pGILDA
plasmid, expressing the LexA protein, were used as control. Aliquots
of cells were stained with trypan blue, a dye used as an indicator of
viability, and the percentage of dead cells was enumerated. (B) Cells
were grown as above, stained with the oxidation sensitive probe HE,
and subjected to ﬂow cytometry to determine the percentage of posi-
tive cells. (C) DYAP1 cells expressing LexA-Bax with BI-GST or Bcl-2
were plated on gal-raﬀ/CM-his, trp media. The absence of YAP1 had
no eﬀect on the protective capacity of BI-GST or Bcl-2.3. Results and discussion
3.1. Coexpression of BI-GST restores viability and removes
ROS
To assess the eﬀect of BI-GST on the viability of yeast cells
expressing Bax, cells growing in liquid cultures were stained
with trypan blue and enumerated by microscopy. After ex-
pression of Bax for 24 h, 25% of cells were dead. The re-
maining cells were in a state of stasis, at the point of the cell
cycle in which LexA-Bax induction ﬁrst occurred, and were
unable to divide [12]. In cells coexpressing BI-GST, cell-death
was reduced to 10% after 24 h (Fig. 1A).
Bax-expression is known to cause a transient increase in
ROS, followed by a drop to slightly lower than wild-type levels
[12]. To assess the eﬀect of BI-GST in intracellular ROS, yeast
cells were stained with HE, a compound used to probe oxi-
dation caused by the respiratory burst, and the percentage of
positively staining cells was determined by FACS analysis.
When wild-type cells were examined, 21% stained positive,
while addition of FCCP, an uncoupler that dissipates the
proton gradient, reduced the number of positive cells to 16%,
indicating that the ﬂuorescence was mostly due to respiration
(Fig. 1B). Expression of Bax increased the number of positive
cells to 33%, while expression of BI-GST reduced the number
of positive staining cells both in the absence and in the pres-
ence of Bax (16% and 27%, respectively).
3.2. Suppression of Bax lethality does not depend on YAP1,
ethacrynic acid (EA), or buthionine sulfoximine (BSO)
The prooxidant protective capacity of BI-GST depends on
the presence of YAP1, a yeast transcriptional regulator of the
oxidative response [13]. However, deletion of YAP1 does not
abolish the capacity of BI-GST to suppress Bax lethality, in-
dicating the presence of distinct pathways for the protection
against prooxidants and Bax expression (Fig. 1C). To examine
the eﬀect of the glutathione detoxiﬁcation system on the ability
of BI-GST to suppress Bax, cells were plated on media sup-
plemented with increasing concentrations of BSO, a com-
pound which reduces intracellular levels of GSH, and EA, a
reversible inhibitor of GSTs. Neither compound had any eﬀect
on the Bax-suppressing capacity of BI-GST (data not shown).
3.3. Mitochondrial alterations
Bax expression in mammalian and yeast cells is character-
ized by the disruption of mitochondrial function and the dis-
sipation of the mitochondrial membrane potential (DWm)
[12,16]. In yeast, at the early stages of Bax-expression, DWm
becomes hyperpolarized and progressively collapses [12,17].
DWm and mitochondrial morphology were assessed using the
Mitotracker Red ﬂuorophore. In cells expressing Bax, the dye
was found to concentrate in fewer mitochondria, which were
signiﬁcantly larger in size compared to wild-type cells (Fig. 2).
Coexpression of Bcl-2 restored mitochondria to wild-type ap-
pearance. While expression of BI-GST alone did not have anyeﬀect on mitochondrial morphology, coexpression of Bax and
BI-GST resulted in clustered mitochondria. These mitochon-
drial alterations were studied further using a plasmid ex-
pressing GFP fused to a mitochondrial matrix targeting
sequence [14]. Wild-type cells showed bright peripheral GFP
ﬂuorescence of several thin tubules representing the mito-
chondria (Fig. 2). Expression of Bax, as in the case of Mito-
tracker staining, caused a dramatic change in the pattern of
ﬂuorescence characterized by a decreased number of swollen
mitochondria. Coexpression of Bcl-2, again, caused complete
reversal of the mitochondrial morphology to wild type ap-
pearance. In contrast, coexpression of BI-GST caused an ag-
gregation of brightly ﬂuorescing and large in diameter tubules,
which in most cases maintained their integrity and did not
fuse.
Changes in mitochondrial morphology have been reported
in numerous systems, frequently resulting from dysfunctions in
Fig. 3. Vacuolar morphology of cells expressing Bax. Eﬀects of BI-
GST and Bcl-2. EGY48 cells expressing LexA-Bax alone or together
with Bcl-2 or BI-GST were stained with MDY-64 and CMAC to vi-
sualize the vacuolar membrane and lumen, respectively. Protein
transport to the vacuole was monitored by transforming cells with a
plasmid expressing an ALP-GFP fusion.
Fig. 2. Mitochondrial alterations caused by Bax. (Left) EGY48 cells
expressing LexA-Bax alone or together with Bcl-2 or BI-GST were
stained with Mitotracker, a dye that localizes to the mitochondria as a
consequence of DWm. (Right) Plasmid pVT100U-mitGFP, which ex-
presses GFP fused to a mitochondrial matrix targeting sequence, was
introduced to the above-mentioned cells to monitor mitochondrial
morphological alterations.
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morphology caused by Bax have also been identiﬁed in
mammalian cells. Bax has been shown to be present in mito-
chondrial constriction sites, separating mitochondria into
several shorter units and promoting apoptosis [19].
3.4. Vacuolar alterations
The recent identiﬁcation of a Bax-tolerant yeast mutant in
the ADP-ribosylation factor-like protein, ARL1, suggested a
potential involvement of the vacuole [20]. To assess the eﬀect
of Bax and BI-GST on vacuolar morphology, we stained cells
with the yeast vacuole membrane ﬂuorophore marker MDY-
64, the blue ﬂuorescent dye CMAC (which accumulates in the
lumen of the vacuole), and the GFP-tagged ALP (which labels
speciﬁcally the vacuolar membrane and can be used to monitor
aspects of protein traﬃc to the vacuole).
Wild-type EGY48 cells, stained with MDY-64 and CMAC,
show one or two well-structured vacuoles (Fig. 3). In a large
number of CMAC stained cells, small endosomal vesicles in
the process of fusion can clearly be seen. Intense ALP-GFP
ﬂuorescence is evident on the vacuolar membranes. Bax-
expressing cells exhibit dramatic alterations in vacuolar mor-
phology. At the early stages of protein expression, vacuoles
become intensely ﬂuorescing non-canonical structures withfoamy appearance (Fig. 3). At later stages, most cells lose
MDY-64 ﬂuorescence and only few show faintly stained
vacuoles. CMAC staining revealed a similar picture, con-
sisting of highly ﬂuorescing cells with fragmented vacuoles
and a progressively increasing number of cells that do not
ﬂuoresce. CMAC does not stain dead cells. However, the
proportion of dead cells (25%, Fig. 1A) is substantially less
than that of non-ﬂuorescing cells (65%), indicating the
presence of a population of viable cells that lack functional
vacuoles. After 24 h of Bax expression, ALP-GFP ﬂuores-
cence is lost from vacuolar membranes giving rise to diﬀused
cytoplasmic staining. A population of cells ﬂuoresces on the
cytoplasmic membrane, indicating missorting of the ALP
protein. When Bcl-2 is coexpressed with Bax, cells exhibit a
similar but not identical morphology to those expressing Bax
alone, with a larger proportion of cells maintaining CMAC
and ALP-GFP ﬂuorescence. Unlike Bcl-2 coexpressing cells,
the cells that coexpress BI-GST have their vacuolar structure
preserved, most of them showing one or two large vacuoles.
Staining with CMAC revealed an intermediate intensity and
regular vacuolar morphology, while intense ﬂuorescence of
the ALP-GFP was seen in vesicles proximal to the main
vacuole.
To examine the site of action of Bax and BI-GST in yeast
cells, we expressed a C-terminal GFP fusion of BI-GST and an
N-terminal EYFP fusion of Bax. At the initial stages of protein
induction, BI-GST-GFP exhibited diﬀused cytoplasmic ﬂuo-
rescence. At later stages, this concentrated in small vesicles in
the proximity of the main vacuole, but it did not fuse to the
latter (Fig. 4A). Fluorescence in structures that may represent
mitochondria could also be seen. EYFP-Bax ﬂuorescence was
substantially weaker. It could be detected in mitochondrial
tubules at the periphery of the cell and as a more diﬀused stain
Fig. 4. (A) Intracellular localization of BI-GST and Bax. (Top) EGY48
cells expressing a BI-GST-GFP fusion were visualized by ﬂuorescent
microscopy (top left) and low intensity bright-ﬁeld/ﬂuorescent mi-
croscopy (top right). (Bottom) EGY48 cells expressing a Bax-EYFP
fusion visualized by ﬂuorescent microscopy. (B) Cells coexpressing Bax
and BI-GST exhibit enhanced autophagy. MDY-64 staining of EGY48
cells coexpressing Bax and BI-GST reveals vacuolar membrane in-
vaginations.
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and its subsequent concentration in vesicles proximal to the
vacuoles could justify its dominant protective eﬀect on the
organelles.
3.5. Autophagy
Cells coexpressing Bax with BI-GST appear to exhibit ex-
tensive autophagy. MDY-64 staining of the vacuolar mem-
brane of cells coexpressing Bax and BI-GST reveals membrane
invaginations, a characteristic of autophagic processes
(Fig. 4B). Evidence for the link between autophagic processes
and Bax expression in yeast has come from the recent dis-
covery of Bax-resistant yeast mutants in which nutrient recy-
cling processes associated with autophagy are compromised
[21]. Autophagy is a unique, membrane-traﬃcking process that
occurs in response to dramatic changes in nutrient availability
in yeast cells, and is also known to occur in plant and animal
cells [22]. In some mammalian systems, active autophagy ap-
pears to increase the tendency of cells to undergo PCD [23]. In
yeast cells, rapid removal of damaged membranes and or-
ganelles by autophagy may be important for maintaining cel-
lular viability. Being the ﬁnal compartment in converging
transport pathways, the vacuole receives endocytic traﬃc from
the cell surface, biosynthetic traﬃc from the Golgi and mate-
rial from the cytoplasm by autophagy [24].The integrity of the lysosome, the mammalian counterpart
of the yeast vacuole, has recently been implicated in the onset
of the apoptotic process. Studies have shown that lysosomal
rupture is an early event when apoptosis is initiated by lyso-
somal damaging agents, oxidative stress, oxidized lipids, serum
withdrawal, Fas ligation and p53-induced apoptosis [23,25,26].
Overexpression of Bcl-2 can inhibit induction of lysosomal
damage by oxidative stress [27]. In this report, Bax expression
in yeast is shown to promote missorting of vacuolar proteins
and disruption of the vacuole. These eﬀects of Bax are likely to
originate at the ER and the Golgi. BI-GST and Bcl-2 appear to
exert their protective eﬀect by a diﬀerent mode, Bcl-2 pre-
dominantly on the mitochondria whereas BI-GST on the up-
stream events aﬀecting vacuolar maintenance. Recent
examination of mutant yeast strains, resistant to Bax, identi-
ﬁed molecular events involved in Bax lethality that are distinct
between mitochondria and the vacuoles [21].4. Conclusion
Oxidative stress appears to be linked to the Bax phenotype.
However, the eﬀects of Bax in yeast cells are pleiotropic and
involve at least two organelles and the delivery pathway. BI-
GST was able to mediate removal of endogenous ROS both in
the presence and absence of Bax. Unlike the protective eﬀect
that BI-GST exerts against prooxidants, which is YAP1-de-
pendent, Bax suppression by BI-GST is YAP1-independent,
suggesting an additional facet of BI-GST function which has
not been elucidated. A connection between ROS production,
mitochondrial localization, vacuolar function, and autophagy,
with replicative senescence has been proposed in the past for
yeast cells. Disruption of the autophagic pathway in plants is
also linked to senescence [28]. Taken together, these results
suggest the presence of conserved underlying pathways of cell
death among eukaryotes.
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